| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.0098 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |